迪皮里达摩尔增强了缺血性预先调节的心肌梗塞大小限制作用
1Second Department of Internal Medicine, Sapporo Medical College, Japan.
Circulation
|September 1, 1992
概括
迪皮里达摩尔通过增加腺受体激活来增强缺血预约的保护作用. 这项研究表明,二皮里达摩尔增强了腺在改善对缺血的耐受性方面的作用.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 缺血性耐受性 缺血性耐受性
背景情况:
- 腺素 (ADO) 受体激活对于预条件诱导的缺血性耐受性至关重要.
- 作为ADO运输抑制剂的二皮里达摩尔被研究其增强预条件效应的潜力.
研究的目的:
- 测试二皮里达摩尔是否增强了缺血预先调节的保护作用.
- 阐明腺在调解预条件诱导的缺血性耐受性中的作用.
主要方法:
- 子经历了冠状动脉封闭和再输血,并评估了心脏病的大小.
- 应用了缺血预条件,有或没有二皮里达摩尔和腺素受体抗剂8-甲 (8-PT).
主要成果:
- 仅仅是缺血预调就显示了限制心脏病发作大小的趋势.
- 迪皮里达摩尔显著增强了预先调节的心脏病发作限制效果.
- 迪皮里达摩尔的增强作用被8-PT显著减弱.
结论:
- 迪皮里达摩尔显著增强了缺血性预先调节的心脏病限制效果.
- 这支持了内源性腺受体刺激调解预条件诱导的缺血性耐受性的假设.
相关概念视频
Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


